|
|
|
|
LEADER |
01956nam a2200325 u 4500 |
001 |
EB000943518 |
003 |
EBX01000000000000000737108 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
150223 r ||| eng |
100 |
1 |
|
|a McDonagh, Marian S.
|
245 |
0 |
0 |
|a Drug class review on agents for overactive bladder
|h Elektronische Ressource
|b final report
|c Marian S. McDonagh ... [et al.]
|
260 |
|
|
|a Portland, Or.
|b Oregon Health & Science University, Evidence-Based Practice Center
|c c2005, 2005
|
300 |
|
|
|a 1 PDF file (215 p.)
|b ill
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Drug Evaluation
|
653 |
|
|
|a United States
|
653 |
|
|
|a Clinical Trials as Topic
|
653 |
|
|
|a Cholinergic Antagonists / therapeutic use
|
653 |
|
|
|a Quality of Life
|
653 |
|
|
|a Urinary Incontinence / drug therapy
|
653 |
|
|
|a Muscarinic Antagonists / therapeutic use
|
653 |
|
|
|a Urinary Bladder, Overactive / drug therapy
|
710 |
2 |
|
|a Oregon Health & Science University
|b Evidence-based Practice Center
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
500 |
|
|
|a "December 2005.". - "The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports."
|
856 |
4 |
0 |
|u http://el.trc.gov.om:4000/htmlroot/MEDICAL/tcolon/pharmacology/Drug%20Effectiveness/E-Books/Drug%20Class%20Review%20on%20Agents%20for%20Overactive%20Bladder.pdf
|3 Volltext
|n Free Electronic Resource
|3 Volltext
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK10412
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|